Cargando…
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
The rapid spread of the highly contagious Omicron variant of SARS-CoV-2 along with its high number of mutations in the spike gene has raised alarm about the effectiveness of current medical countermeasures. To address this concern, we measured neutralizing antibodies against Omicron in three importa...
Autores principales: | Lusvarghi, Sabrina, Pollett, Simon D., Neerukonda, Sabari Nath, Wang, Wei, Wang, Richard, Vassell, Russell, Epsi, Nusrat J., Fries, Anthony C, Agan, Brian K, Lindholm, David A., Colombo, Christopher J., Mody, Rupal, Ewers, Evan C., Lalani, Tahaniyat, Ganesan, Anuradha, Goguet, Emilie, Hollis-Perry, Monique, Coggins, Si’Ana A., Simons, Mark P., Katzelnick, Leah C., Wang, Gregory, Tribble, David R., Bentley, Lisa, Eakin, Ann E., Broder, Christopher C., Erlandson, Karl J., Laing, Eric D., Burgess, Timothy H., Mitre, Edward, Weiss, Carol D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722594/ https://www.ncbi.nlm.nih.gov/pubmed/34981057 http://dx.doi.org/10.1101/2021.12.22.473880 |
Ejemplares similares
-
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies
por: Lusvarghi, Sabrina, et al.
Publicado: (2022) -
SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity
por: Neerukonda, Sabari Nath, et al.
Publicado: (2021) -
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history
por: Wang, Wei, et al.
Publicado: (2022) -
Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects
por: Lusvarghi, Sabrina, et al.
Publicado: (2022) -
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants
por: Neerukonda, Sabari Nath, et al.
Publicado: (2022)